Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome.
Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome. Research Abstract Details
Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome. Publishing Authors By Initials
Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome. Journal Published:
PUBLICATION TYPE: Letter
Journal: American journal of hematology
VOLUME: 82
Page Numbers: 501-2
Journal Abbreviation: Am. J. Hematol.
ISSN: 0361-8609
DAY: 26
MONTH: Jun
YEAR: 2007
Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 7610369
Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome. Keywords Mesh Terms:
KEYWORDS: Treatment Failure
MESH TERMS: administration & dosage
Chemical & Substance for Abstract: Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome. Information
Substance Name: imatinib
Registry Number: 152459-95-5
Grant and Affiliation Information for Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome.
AFFILIATION:
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Am J Hematol
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome Related Publications